FINOTTI, PAOLA
 Distribuzione geografica
Continente #
NA - Nord America 3.675
AS - Asia 2.042
EU - Europa 1.033
SA - Sud America 335
AF - Africa 265
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 16
Totale 7.393
Nazione #
US - Stati Uniti d'America 3.496
SG - Singapore 749
CN - Cina 404
DE - Germania 282
VN - Vietnam 224
BR - Brasile 204
HK - Hong Kong 196
FI - Finlandia 111
FR - Francia 82
UA - Ucraina 73
IT - Italia 66
IN - India 62
SE - Svezia 59
GB - Regno Unito 55
PL - Polonia 35
BD - Bangladesh 34
AR - Argentina 32
PK - Pakistan 32
RU - Federazione Russa 26
TR - Turchia 26
NL - Olanda 25
PH - Filippine 23
EC - Ecuador 22
CA - Canada 21
MX - Messico 20
SA - Arabia Saudita 19
JP - Giappone 18
PS - Palestinian Territory 18
BE - Belgio 16
MY - Malesia 16
UZ - Uzbekistan 16
IQ - Iraq 15
ZA - Sudafrica 15
CO - Colombia 14
ID - Indonesia 14
JO - Giordania 14
VE - Venezuela 14
JM - Giamaica 13
GM - Gambi 12
HU - Ungheria 12
MA - Marocco 12
PR - Porto Rico 12
TN - Tunisia 12
UY - Uruguay 12
ES - Italia 11
KE - Kenya 11
PT - Portogallo 11
AE - Emirati Arabi Uniti 10
AT - Austria 10
BB - Barbados 10
CL - Cile 10
IE - Irlanda 10
KG - Kirghizistan 10
KZ - Kazakistan 10
LA - Repubblica Popolare Democratica del Laos 10
NC - Nuova Caledonia 10
RS - Serbia 10
SI - Slovenia 10
SN - Senegal 10
YE - Yemen 10
AL - Albania 9
AZ - Azerbaigian 9
IR - Iran 9
MK - Macedonia 9
TH - Thailandia 9
XK - ???statistics.table.value.countryCode.XK??? 9
AF - Afghanistan, Repubblica islamica di 8
AM - Armenia 8
BZ - Belize 8
CH - Svizzera 8
CR - Costa Rica 8
CU - Cuba 8
CV - Capo Verde 8
DO - Repubblica Dominicana 8
EE - Estonia 8
GE - Georgia 8
GF - Guiana Francese 8
GR - Grecia 8
HR - Croazia 8
KH - Cambogia 8
MW - Malawi 8
PY - Paraguay 8
RW - Ruanda 8
TT - Trinidad e Tobago 8
UG - Uganda 8
AO - Angola 7
BG - Bulgaria 7
CI - Costa d'Avorio 7
CW - ???statistics.table.value.countryCode.CW??? 7
EG - Egitto 7
GH - Ghana 7
LB - Libano 7
LT - Lituania 7
MZ - Mozambico 7
NI - Nicaragua 7
RO - Romania 7
VC - Saint Vincent e Grenadine 7
YT - Mayotte 7
AD - Andorra 6
BJ - Benin 6
Totale 7.105
Città #
Singapore 480
Ashburn 415
San Jose 408
Fairfield 274
Jacksonville 238
Chandler 224
Woodbridge 217
Ann Arbor 198
Houston 192
Hong Kong 181
Wilmington 132
Cambridge 115
Seattle 99
Beijing 93
Princeton 77
Boardman 66
Helsinki 63
Hanoi 57
Ho Chi Minh City 57
Santa Clara 55
Los Angeles 51
Lauterbourg 43
Nanjing 40
Roxbury 32
San Diego 32
Des Moines 31
Medford 29
Nürnberg 25
São Paulo 23
Dong Ket 22
New York 22
Padova 22
Shenyang 20
Guangzhou 19
Bytom 17
Tashkent 15
Chicago 14
Amman 13
Hebei 13
Orem 13
Warsaw 13
Boston 12
Buffalo 12
Tokyo 12
Kingston 11
Atlanta 10
Dakar 10
Kuala Lumpur 10
Lahore 10
Noumea 10
Stockholm 10
Bishkek 9
Bridgetown 9
Da Nang 9
Montevideo 9
Nairobi 9
Norwalk 9
Redwood City 9
Vientiane 9
Baku 8
Council Bluffs 8
Dublin 8
Frankfurt am Main 8
Kampala 8
Kigali 8
New Delhi 8
Phnom Penh 8
Toronto 8
Vienna 8
Yerevan 8
Abu Dhabi 7
Accra 7
Athens 7
Bangkok 7
Belize City 7
Guayaquil 7
Haiphong 7
Havana 7
Jinan 7
Kingstown 7
Lilongwe 7
Managua 7
Montreal 7
Riyadh 7
Rome 7
San Francisco 7
San José 7
San Juan 7
Skopje 7
Abidjan 6
Andorra la Vella 6
Bamako 6
Banjul 6
Brooklyn 6
Brussels 6
Conakry 6
Dallas 6
Dushanbe 6
Hyderabad 6
Ljubljana 6
Totale 4.616
Nome #
Identification and purification from the plasma of Type 1 diabetic subjects of a proteolytically active Grp94Evidence that Grp94 is entirely responsible for plasma proteolytic activity. 299
Grp94 in complexes with IgG is a soluble diagnostic marker of gastrointestinal tumors and displays immune-stimulating activity on peripheral blood immune cells 288
Crucial role of HSP90 in the Akt-dependent promotion of angiogenic-like effect of Glucose-regulated protein94 (Grp94)-IgG complexes 258
Angiogenic transforming capacity of IgG purified from plasma of type 1 diabetic patients 249
Stable complexes formed by Grp94 with human IgG promoting angiogenic differentiation of HUVECs by a cytokine-like mechanism. 242
Human IgGs induce synthesis and secretion of IgGs and neonatal Fc receptor in human umbilical vein endothelial cells 241
Proteomic investigation on Grp94-IgG complexes circulating in plasma of type 1 diabetic subjects 238
Structural Insights into Complexes of Glucose-Regulated Protein94 (Grp94) with Human Immunoglobulin G. Relevance for Grp94-IgG Complexes that Form In Vivo in Pathological Conditions 231
Characterization of immune complexes of idiotypic catalytic and anti-idiotypic inhibitory antibodies in plasma of type 1 diabetic subjects 230
Alteration of plasma proteinase-antiproteinase system in type 1 diabetic patients. Influence of sex and relationship with metabolic control. 213
Long-term blood glucose control and diabetic retinopathy. 201
Comment on: Antibodies to the endoplasmic reticulum-resident chaperones calnexin, Bip and Grp94 in patients with rheumatoid arthritis and systemic lupus erythematosus 201
Effects of Glucose-regulated protein94 (Grp94) on Ig secretion from human blood mononuclear cells 187
The role played by serine proteases in the development and worsening of vascular complications in Type 1 diabetes mellitus. 178
Albumin contamination of a purified human alpha1-antitrypsin preparation does not affect either structural conformation or the electrophoretic mobility of the inhibitor. 165
Mechanism of Na+/K(+)-ATPase activation by trypsin and kallikrein. 162
Inhibition of immunoglobulin secretion from peripheral blood mononuclear cells by glucose-regulated protein94 (Grp94) inallergic subjects 157
[Effects of digoxin on plasma renin activity in man. II]. 157
Immune complexes of Glucose-regulated protein94 (Grp94) with IgG are present in the plasma of Type 1 diabetic subjects and show strong angiogenic-transforming capacity on HUVECs (oral communication) 155
A heat shock protein70 fusion protein with alpha(1)-antitrypsin in plasma of Type 1 diabetic subjects 152
Biphasic pattern of heparin-induced oxidative degradation of trypsin in the presence of glucose. 150
Immune complexes of glucose-regulated protein94 (Grp94) with IgG, present in the plasma of type 1 diabetic subjects, show strong angiogenic-transforming capacity on HUVECs 149
Effects of Glucose-Regulated Protein94 (GRP94) and complexes of GRP94 with IgG on cells of the innate and adaptive immunity (SIF award for the best oral communication) 147
Complexes of Grp94 with human Immunoglobulin G 147
Separation by heparin-affinity chromatography of catalytically active and inactive forms of trypsin which retain the (Na-K)ATPase stimulating property. 147
Complessi di Grp94 ed Immunoglobuline G umane 146
Reduction of erythrocyte (Na+-K+)ATPase activity in type 1 (insulin-dependent) diabetic subjects and its activation by homologous plasma. 146
Differential Mechanism for structural and functional alterations of trypsin by heparin, evidence for a speific radical-generating mechanism at low heparin concentrations. 136
Role of reducing terminals in unfractionated and low-molecular-mass heparins in causing free radical generation and loss of structure and activity of tripsin. 132
Heparin-induced structural modifications and oxidative cleavage of human serum albumin in the absence and presence of glucose. 131
Differential effects of heparin and glucose on structural conformation of human alpha1-antitrypsin: evidence for a heparin-induced cleaved form of the inhibitor. 130
The oxidative mechanism of heparin interferes with radical production by glucose and reduces the degree of glycooxidative modifications on human serum albumin 128
Kinetic studies with competitive inhibitors indicate a sequential mechanism for dopamine beta-hydroxylase. 127
Effects of intact and reduced reducing termini in heparin on structural and functional modifications of trypsin. 120
Effects of digoxin on plasma renin activity in hypertensive patients. 119
Induction of angiogenesis by the heat shock protein Glucose-regulated protein94 (Grp94) mediated by a cytokine-like mechanism. 115
Inhibition of dopamine beta-hydroxylase by captopril. 109
Heparin-induced structural and functional alterations of bovine trypsin. 108
New insights into the molecular mechanism of heparin-protein interactions. Revisiting the role and function of heparin in the light of its oxidative property 103
Both a serine-like protease and a protease inhibitory activity are present in circulating immune complexes in type 1 diabetes mellitus. 102
Spin-trapping agent alpha-phenyl N-tert-butylnitrone binds to trypsin and enhances heparin-induced inhibition of amidolytic activity and structural degradation of the enzyme. 97
Sex and parental hypertension as predictors of worsened red blood cell membrane enzyme activities in type 1 insulin-dependent diabetic subjects. 96
Heparin effects on glycated human serum albumin 88
IDENTIFICAZIONE DI UNA " GLUCOSE-REGULATED PROTEIN" 94 GRP94 MODIFICATA E USO DELLA STESSA E DI ANTICORPI ANTI-GRP94 NELLE COMPLICANZE VASCOLARI DEL DIABETE 84
Spin-trapping agent alpha-phenyl N-Tert-butylnitrone as inhibitor of trypsin and enhancer of the oxidative degradation of the enzyme by heparin 84
Purification of proteinase-like and Na+/K(+)-ATPase stimulating substance from plasma of insulin-dependent diabetics and its identification as alpha 1-antitrypsin 81
Inhibition of enzymes and enzyme by phenothiazines and their radicals. In: Phenothiazienes and 1,4-benzothiazines 75
Totale 7.401
Categoria #
all - tutte 20.998
article - articoli 17.042
book - libri 269
conference - conferenze 0
curatela - curatele 0
other - altro 233
patent - brevetti 765
selected - selezionate 0
volume - volumi 0
Totale 39.307


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021101 0 0 0 0 0 0 0 0 0 0 60 41
2021/2022474 4 64 44 42 21 38 16 47 26 9 45 118
2022/2023454 90 63 12 42 68 76 0 31 41 1 25 5
2023/2024224 17 34 29 19 31 15 18 5 2 3 26 25
2024/2025851 0 37 35 51 138 25 36 63 84 20 150 212
2025/20263.438 128 278 387 528 361 159 491 343 381 232 150 0
Totale 7.401